WASHINGTON — It’s not every day that the pharmaceutical industry, the NAACP, a cancer center, and a nonpartisan think tank are all lobbying to achieve the same policy goal.
But an effort to expand Medicare coverage for obesity drugs has managed to unite them all, and many more groups across the health care industry, too.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
